Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.
暂无分享,去创建一个
C M Rutter | C. Rutter | S. Taplin | M. Laya | M. Mandelson | D. Seger | S Taplin | M T Mandelson | M B Laya | D J Seger
[1] P. Porter,et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.
[2] Anne M Kavanagh,et al. Hormone replacement therapy and accuracy of mammographic screening , 2000, The Lancet.
[3] B. V. VON Schoultz,et al. Mammographic breast density during hormone replacement therapy: differences according to treatment. , 1999, American journal of obstetrics and gynecology.
[4] J. Estève,et al. Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme , 1999, Journal of medical screening.
[5] J. Litherland,et al. The effect of hormone replacement therapy on the sensitivity of screening mammograms. , 1999, Clinical radiology.
[6] A. LaCroix,et al. Are long-term hormone replacement therapy users different from short-term and never users? , 1999, American journal of epidemiology.
[7] L W Bassett,et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. , 1999, Annals of internal medicine.
[8] E. Wagner,et al. Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] S. Taplin,et al. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. , 1996, Journal of the National Cancer Institute.
[10] J. Gabrielsson,et al. Pharmacokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics. , 1996, Acta obstetricia et gynecologica Scandinavica. Supplement.
[11] E B Larson,et al. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. , 1995, Radiology.
[12] M. Bracken,et al. Clinically useful measures of effect in binary analyses of randomized trials. , 1994, Journal of clinical epidemiology.
[13] A. Oza,et al. Mammographic parenchymal patterns: a marker of breast cancer risk. , 1993, Epidemiologic reviews.
[14] N. Boyd,et al. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. , 1992, Cancer detection and prevention.
[15] M. Michell,et al. The mammographic parenchymal patterns of women on hormonal replacement therapy. , 1991, Clinical radiology.
[16] R N Hoover,et al. Mammographic densities and risk of breast cancer , 1991, Cancer.
[17] P. Stomper,et al. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. , 1990, Radiology.
[18] J. Berkowitz,et al. Hormonal replacement therapy: mammographic manifestations. , 1990, Radiology.
[19] M. Szklo,et al. Mammographic parenchymal patterns and breast cancer risk. , 1987, Epidemiologic reviews.
[20] L. Gray,et al. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal patterns. , 1980, Cancer.